Back

Burden of comorbidities, quality of anticoagulation control and outcomes: an analysis from the AFFIRM study

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

9 More presentations in this session

Presentation thumbnail
Doctor J. Oikawa (Sagamihara, JP)
Abstract
Presentation thumbnail
Doctor J. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Doctor K. Agnihotri (Little Rock, US)
Abstract Slides
Presentation thumbnail
Doctor S. Patlolla (Rochester, US)
Abstract
Presentation thumbnail
Doctor F. Pieralli (Florence, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Atrial fibrillation: epidemiology, prognosis, outcome

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Webinar
Anticoagulation challenges in older subjects with multimorbidity
25 July 2023
thumbnail
Congress Presentation
The impact of multimorbidity on mortality in heart failure with reduced ejection fraction (HFrEF): Which comorbidities matter most?
30 June 2021
thumbnail
Congress Presentation
Association between thromboembolic and bleeding risk with adverse outcomes in contemporary European atrial fibrillation patients: final analysis from the ESC-EHRA EORP AF general long-term registry
23 April 2021
thumbnail
Congress Presentation
Association between comprehensive management of cardiovascular comorbidities and the risk of stroke in patients with new-onset atrial fibrillation
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources